![]() |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
|
|||
![]() |
||||
CELL Therapeutics Inc. A class action lawsuit has been commenced on behalf of all persons and entities who purchased or otherwise acquired the securities of CTI between June 7, 2004 and March 4, 2005, inclusive (the "Class Period"), seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act"). The Complaint names CTI Corp., Max Link, and James Bianco as Defendants. Click here to view the complaint. Click here to view press release. Click here to join this class action. Click here to download Adobe Acrobat Reader free of charge. To find out more about this case, please contact us at shareholderrelations@spornlaw.com or 212-964-0046. |
· In re Nicor, Inc. Securities Litigation, 02-CV-5168 (N.D. Ill.) · In re Westar Energy, Inc. Securities Litigation, 03-CV-4003 (D. Kansas) · In re PNC Finacial Services Group, Inc. Securities Litigation, 02-CV-271(W.D. Penn.) · In re SPX Corp. Securities Litigation, 3:04-CV-99 (W.D.N.C.)
· Map Management, LLC · HGK Asset Management |
|||
| Schoengold Sporn Laitman & Lometti, P.C., Cannon's Walk, 19 Fulton Street, Suite 406, New York, NY 10038, Tel: 212-964-0046, Fax: 212-267-8137 © Copyright 2005 - , Schoengold Sporn Laitman & Lometti. All Rights Reserved. Privacy Policy & Disclaimer |
||||